Literature DB >> 11470334

Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities.

S J van Rensburg1, F C Potocnik, T Kiss, F Hugo, P van Zijl, E Mansvelt, M E Carstens, P Theodorou, P R Hurly, R A Emsley, J J Taljaard.   

Abstract

Chronic fatigue syndrome is defined by the Atlanta Centers for Disease Control (Atlanta, GA, USA) as debilitating fatigue lasting for longer than 6 months. Symptoms include disturbances of cognition. Certain factors have in the past been shown to influence cognition, including metals such as aluminum, iron, and zinc; and steroids such as dehydroepiandrosterone. In the present study, concentrations of these factors were determined in the serum and plasma of patients and their age- and gender-matched healthy controls (10 women and 5 men in each group). In addition, copper, dehydroepiandrosterone sulphate, cortisol, cholesterol, hemoglobin, ferritin and transferrin concentrations, as well as transferrin genetic subtypes were determined in both groups. The results indicate that patients had significantly increased serum aluminum and decreased iron compared to controls. In the females, serum iron and dehydroepiandrosterone sulphate were significantly decreased and correlated. Total cholesterol was significantly increased, and significantly negatively correlated with dehydroepiandrosterone sulphate. There were no differences in zinc, copper, cortisol, hemoglobin, transferrin and ferritin concentrations, or in transferrin genetic subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470334     DOI: 10.1016/s0361-9230(01)00478-6

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

2.  The Relationship of Fatigue and Depression with Trace Element Levels in Epileptic Patients.

Authors:  Ayşe Gündoğdu; Ömer Faruk Bolattürk; Recep Aygül; Fikret Akyürek
Journal:  Biol Trace Elem Res       Date:  2022-05-03       Impact factor: 3.738

3.  Metallomic profiling and linkage map analysis of early Parkinson's disease: a new insight to aluminum marker for the possible diagnosis.

Authors:  Shiek S S J Ahmed; Winkins Santosh
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

Review 4.  Biopersistence and brain translocation of aluminum adjuvants of vaccines.

Authors:  Romain Kroum Gherardi; Housam Eidi; Guillemette Crépeaux; François Jerome Authier; Josette Cadusseau
Journal:  Front Neurol       Date:  2015-02-05       Impact factor: 4.003

5.  Changes in fatigue, autonomic functions, and blood biomarkers due to sitting isometric yoga in patients with chronic fatigue syndrome.

Authors:  Takakazu Oka; Tokusei Tanahashi; Nobuyuki Sudo; Battuvshin Lkhagvasuren; Yu Yamada
Journal:  Biopsychosoc Med       Date:  2018-04-10

6.  The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome.

Authors:  Tayfun Turan; Hasan Basri Izgi; Saliha Ozsoy; Fatih Tanrıverdi; Mustafa Basturk; Akif Asdemir; Aslı Beşirli; Ertugrul Esel; Seher Sofuoglu
Journal:  Psychiatry Investig       Date:  2009-06-23       Impact factor: 2.505

7.  The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated.

Authors:  Andrea Burri; Soshiro Ogata; Gregory Livshits; Frances Williams
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.